Literature DB >> 21963702

Antipsychotics as antidepressants: what is the mechanism?

Marina Sagud1, Alma Mihaljević-Peleš, Dražen Begić, Bjanka Vuksan-Ćusa, Milivoj Kramarić, Maja Zivković, Miro Jakovljević.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21963702

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN： 0353-5053            Impact factor:   1.063


× No keyword cloud information.
  8 in total

Review 1.  Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Authors:  Marc Krause; Yikang Zhu; Maximilian Huhn; Johannes Schneider-Thoma; Irene Bighelli; Adriani Nikolakopoulou; Stefan Leucht
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-01-24       Impact factor: 5.270

Review 2.  Clinical issues in use of atypical antipsychotics for depressed patients.

Authors:  Chi-Un Pae; Ashwin A Patkar
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

Review 3.  Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews.

Authors:  Michele Fornaro; Domenico De Berardis; Giampaolo Perna; Marco Solmi; Nicola Veronese; Laura Orsolini; Elisabetta Filomena Buonaguro; Felice Iasevoli; Cristiano André Köhler; André Ferrer Carvalho; Andrea de Bartolomeis
Journal:  Biomed Res Int       Date:  2017-05-09       Impact factor: 3.411

4.  Aripiprazole-induced sleep-related eating disorder: a case report.

Authors:  Nobuyuki Kobayashi; Masahiro Takano
Journal:  J Med Case Rep       Date:  2018-04-05

Review 5.  Major Depressive Disorder (MDD) and Schizophrenia- Addressing Unmet Needs With Partial Agonists at the D2 Receptor: A Review.

Authors:  Jasmina Mallet; Philip Gorwood; Yann Le Strat; Caroline Dubertret
Journal:  Int J Neuropsychopharmacol       Date:  2019-10-01       Impact factor: 5.176

6.  Untreated depressive symptoms significantly worsen quality of life in old age and may lead to the misdiagnosis of dementia: a cross-sectional study.

Authors:  Viktor Voros; Sandor Fekete; Tamas Tenyi; Zoltan Rihmer; Ilona Szili; Peter Osvath
Journal:  Ann Gen Psychiatry       Date:  2020-09-15       Impact factor: 3.455

Review 7.  Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice.

Authors:  Changsu Han; Sheng-Min Wang; Soo-Jung Lee; Tae-Youn Jun; Chi-Un Pae
Journal:  Chonnam Med J       Date:  2015-08-17

Review 8.  Use of antipsychotics in the treatment of depressive disorders.

Authors:  Ping Wang; Tianmei Si
Journal:  Shanghai Arch Psychiatry       Date:  2013-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.